FABP1 and fatty liver disease: Therefore it is likely that under the regulation of FOXA2 and Nrf2 diminished endogenous ALR levels in hepatic steatosis result in altered expression of lipid metabolizing genes such as ELOVL6, SCD1, CPT1α as well as FABP1.